The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Epiccocarines A ID: ALA5282916
Max Phase: Preclinical
Molecular Formula: C23H31NO4
Molecular Weight: 385.50
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC/C=C(\C)C[C@H](C)C[C@H](C)/C(O)=C1/C(=O)N[C@@H](Cc2ccc(O)cc2)C1=O
Standard InChI: InChI=1S/C23H31NO4/c1-5-6-14(2)11-15(3)12-16(4)21(26)20-22(27)19(24-23(20)28)13-17-7-9-18(25)10-8-17/h6-10,15-16,19,25-26H,5,11-13H2,1-4H3,(H,24,28)/b14-6+,21-20-/t15-,16-,19-/m0/s1
Standard InChI Key: KGVANRZKBPUYPV-PWFBFJQWSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
-4.6098 -0.4370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8952 -0.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1832 -0.4366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1832 -1.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8934 -1.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6098 -1.2655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3244 -1.6781 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4686 -0.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7539 -0.4366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0005 -0.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4484 -0.7141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8609 -1.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6677 -1.2569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4485 -2.1427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3762 -0.7141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7885 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3762 0.7142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6132 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0256 0.7142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8503 0.7142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2626 1.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0873 1.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4997 2.1427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3244 2.1427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8503 2.1427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6132 1.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7885 -1.4283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7870 0.6954 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
3 8 1 0
9 8 1 1
10 9 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 9 1 0
12 14 2 0
11 15 2 0
15 16 1 0
16 17 1 1
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
21 25 1 0
19 26 1 1
15 27 1 0
10 28 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.50Molecular Weight (Monoisotopic): 385.2253AlogP: 4.22#Rotatable Bonds: 8Polar Surface Area: 86.63Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.04CX Basic pKa: ┄CX LogP: 4.69CX LogD: 2.36Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.27Np Likeness Score: 1.45
References 1. Mishra SK, Tripathi G, Kishore N, Singh RK, Singh A, Tiwari VK.. (2017) Drug development against tuberculosis: Impact of alkaloids., 137 [PMID:28628823 ] [10.1016/j.ejmech.2017.06.005 ]